Pfizer wins EU approval for $15 billion Hospira buy

BRUSSELS (Reuters) - U.S. drugmaker Pfizergained European Union antitrust approval on Tuesday for its proposed $15 billion acquisition of U.S. rival Hospiraafter pledging to sell some drugs to...